2015 AIChE Annual Meeting Proceedings

Session: Product Quality Attribute Monitoring and Control in Drug Substance Manufacturing

Ensuring drug substance production processes remain robust yet ensuring patient safety and drug efficacy is founded on understanding and control of both the process and the product. An understanding of the product requires knowledge of how the product interacts with human physiology leading to an understanding of critical quality attributes that supports efficacy and safety. This understanding is then translated into the process design and characterization of operating space. This session covers the identification and understanding of product quality attribute identification, characterization, and related process/product monitoring and control.

Chair

Gregory Frank, Amgen Inc.

Co-Chair

Praveen Sharma, Infinity Pharmaceuticals

Presentations

03:15 PM

Michael Sokolov, Alessandro Butté, Massimo Morbidelli

03:38 PM

Sharat Varma, Florian Krattenmacher, Natarajan Vijayasankaran, Steven Meier, Christopher Yu

04:01 PM

04:24 PM

Michael Sokolov, Daniel Karst, Vania Bertrand, Miroslav Soos, Massimo Morbidelli, Alessandro Butté

04:47 PM

05:10 PM

Christopher Mancinelli, Jennifer Monaldi, Johnny Chowoe, Stelios Tsinontides, James Wright, Eda Ross Montgomery, Mani Sundararajan, Maury Winkler, Marty Shelton